Skip to main content
. 2016 Aug 30;5(9):e003505. doi: 10.1161/JAHA.116.003505

Table 3.

Hazard Ratios and 95% CI for the Association of AHA‐Defined Categories of Physical Activity With Risk for Incident ASCVD Over 21 Years Follow‐Up by Family History Status: The ARIC Study 1987–2012

Poor Intermediate Recommended
No family history of premature CHDe (n=9006)
N events 618 377 550
N total 3065 2329 3612
Incidence ratea 9.8 (9.1, 10.6) 7.7 (6.9, 8.5) 7.2 (6.6, 7.8)
Model 1b Ref 0.82 (0.72, 0.93) 0.70 (0.62, 0.79)
Model 2c Ref 0.91 (0.80, 1.04) 0.83 (0.73, 0.94)
Model 3d Ref 0.89 (0.78, 1.02) 0.83 (0.73, 0.94)
Family history of premature CHDe (n=990)
N events 67 46 65
N total 333 253 404
Incidence ratea 10.1 (7.9, 12.8) 8.7 (6.5, 11.6) 7.6 (6.0, 9.7)
Model 1b Ref 0.92 (0.63, 1.35) 0.76 (0.54, 1.09)
Model 2c Ref 1.02 (0.69, 1.51) 0.92 (0.63, 1.33)
Model 3d Ref 0.98 (0.66, 1.46) 0.80 (0.55, 1.17)

AHA indicates American Heart Association; ARIC, Atherosclerosis Risk in Communities; ASCVD, atherosclerotic cardiovascular disease; BMI, body mass index; CHD, coronary heart disease; FHx, family history; GFR, glomerular filtration rate; HDL, high‐density lipoprotein; LDL, low‐density lipoprotein; PA, physical activity.

a

Incidence rate is per 1000 person‐years.

b

Model 1: Age, sex, race/center.

c

Model 2: Model 1+education, BMI, smoking status, and alcohol intake.

d

Model 3: Model 2+additional potential mediating variables (of the association between PA and ASCVD risk)−systolic blood pressure, antihypertensive medication use, diabetes, LDL cholesterol, HDL cholesterol, triglycerides, use of lipid‐lowering medications, and estimated GFR.

e

P‐interaction for FHx (Model 2)=0.680.